S&P 500 7,500.58 ▲ 80.48 (+1.08%) DOW 51,564.70 ▲ 72.15 (+0.14%) NASDAQ 26,517.93 ▲ 496.28 (+1.91%) US Markets Closed â€ĸ 03:59 AM ET

FTH

Sensei Biotherapeutics, Inc. Common Stock

Price Chart
Latest Quote

$17.82

+1.17 (+7.03%)
Current Price
Previous Close $16.65
Open $17.24
Day High $19.65
Day Low $16.42
Volume 65,785
Fetched: 2026-06-19T07:59:38
Stock Information
Exchange NGM
📊 Comprehensive Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
Insider & Institutional transactions data not available
Valuation Ratios
Analyst Data
Recommendationstrong_buy
Target Price$52.50
Technical Indicators
SMA20$15.69
SMA50$22.11
SMA200$16.41
RSI41.21
ATR2.7657
Rel Volume0.95
Performance History
Week+65.15%
Month+6.26%
Quarter-41.67%
6 Months+120.54%
YTD+84.76%
Year+172.06%
3 Years-34.00%
5 Years-92.57%
10 Years-95.29%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-18 $17.82 65,900
2026-06-17 $16.65 166,900
2026-06-16 $14.53 155,500
2026-06-15 $13.85 219,700
2026-06-12 $13.00 58,000
2026-06-11 $10.79 71,100
2026-06-10 $11.41 52,000
2026-06-09 $12.63 55,600
2026-06-08 $13.00 49,500
2026-06-05 $14.65 50,800
2026-06-04 $16.60 36,800
2026-06-03 $15.85 44,500
2026-06-02 $16.09 60,500
2026-06-01 $19.79 66,900
2026-05-29 $21.14 70,000
2026-05-28 $17.59 40,500
2026-05-27 $16.65 53,500
2026-05-26 $16.47 27,200
2026-05-22 $17.79 21,100
2026-05-21 $17.56 16,000
2026-05-20 $17.58 26,400
2026-05-19 $16.77 51,500
Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Total Revenue $0 $0 $0 $0
Operating Revenue $0 $0 $0 $0
Expenses
Interest Expense $32,000 $90,000 $144,000 $219,000
Total Expenses $22,288,000 $31,663,000 $37,064,000 $50,188,000
Other Income Expense $-4,000 $-954,000 $-517,000 $36,000
Other Non Operating Income Expenses $-4,000 $-3,000 $-215,000 $36,000
Net Non Operating Interest Income Expense $1,207,000 $2,460,000 $3,480,000 $1,564,000
Interest Expense Non Operating $32,000 $90,000 $144,000 $219,000
Operating Expense $22,288,000 $31,663,000 $37,064,000 $50,188,000
General And Administrative Expense $11,328,000 $13,036,000 $18,765,000 $19,805,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-21,085,000 $-30,157,000 $-34,101,000 $-48,588,000
Net Interest Income $1,207,000 $2,460,000 $3,480,000 $1,564,000
Interest Income $1,239,000 $2,550,000 $3,624,000 $1,783,000
Normalized Income $-21,085,000 $-29,206,000 $-33,799,000 $-48,588,000
Net Income From Continuing And Discontinued Operation $-21,085,000 $-30,157,000 $-34,101,000 $-48,588,000
Total Operating Income As Reported $-22,288,000 $-32,614,000 $-37,064,000 $-50,188,000
Net Income Common Stockholders $-21,085,000 $-30,157,000 $-34,101,000 $-48,588,000
Net Income $-21,085,000 $-30,157,000 $-34,101,000 $-48,588,000
Net Income Including Noncontrolling Interests $-21,085,000 $-30,157,000 $-34,101,000 $-48,588,000
Net Income Continuous Operations $-21,085,000 $-30,157,000 $-34,101,000 $-48,588,000
Pretax Income $-21,085,000 $-30,157,000 $-34,101,000 $-48,588,000
Special Income Charges $0 $-951,000 $-302,000 $0
Interest Income Non Operating $1,239,000 $2,550,000 $3,624,000 $1,783,000
Operating Income $-22,288,000 $-31,663,000 $-37,064,000 $-50,188,000
Per Share
Diluted EPS $-16.72 $-24.00 $-24.40 $-31.60
Basic EPS $-16.72 $-24.00 $-24.40 $-31.60
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-20,914,000 $-27,794,000 $-32,304,000 $-47,022,000
Total Unusual Items $0 $-951,000 $-302,000 $0
Total Unusual Items Excluding Goodwill $0 $-951,000 $-302,000 $0
Reconciled Depreciation $139,000 $1,322,000 $1,351,000 $1,347,000
EBITDA (Bullshit earnings) $-20,914,000 $-28,745,000 $-32,606,000 $-47,022,000
EBIT $-21,053,000 $-30,067,000 $-33,957,000 $-48,369,000
Diluted Average Shares $1,260,772 $1,255,861 $1,397,642 $1,535,164
Basic Average Shares $1,260,772 $1,255,861 $1,397,642 $1,535,164
Diluted NI Availto Com Stockholders $-21,085,000 $-30,157,000 $-34,101,000 $-48,588,000
Impairment Of Capital Assets $0 $951,000 $0 -
Research And Development $10,960,000 $18,627,000 $18,299,000 $30,383,000
Selling General And Administration $11,328,000 $13,036,000 $18,765,000 $19,805,000
Other Gand A $11,328,000 $13,036,000 $18,765,000 $19,805,000
Gain On Sale Of Ppe - $0 $-302,000 $0
Other Special Charges - - - -
Fetched: 2026-06-17
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $18,592,000 $38,386,000 $64,895,000 $103,407,000
Total Assets $22,902,000 $45,361,000 $74,374,000 $118,375,000
Total Non Current Assets $1,395,000 $3,432,000 $7,124,000 $9,786,000
Other Non Current Assets $18,000 $48,000 $86,000 $63,000
Current Assets $21,507,000 $41,929,000 $67,250,000 $108,589,000
Other Current Assets $92,000 $120,000 $325,000 $344,000
Prepaid Assets $231,000 $474,000 $1,168,000 $1,129,000
Cash Cash Equivalents And Short Term Investments $21,184,000 $41,335,000 $65,757,000 $107,116,000
Cash And Cash Equivalents $8,668,000 $9,994,000 $13,011,000 $17,795,000
Current Deferred Assets - - - -
Debt
Total Debt $1,509,000 $3,845,000 $6,208,000 $8,033,000
Long Term Debt And Capital Lease Obligation $59,000 $1,527,000 $3,769,000 $5,902,000
Current Debt And Capital Lease Obligation $1,450,000 $2,318,000 $2,439,000 $2,131,000
Liabilities
Total Liabilities Net Minority Interest $4,310,000 $6,975,000 $9,479,000 $14,968,000
Total Non Current Liabilities Net Minority Interest $59,000 $1,527,000 $3,836,000 $5,902,000
Current Liabilities $4,251,000 $5,448,000 $5,643,000 $9,066,000
Other Current Liabilities $77,000 $126,000 - -
Payables And Accrued Expenses $1,404,000 $1,122,000 $1,694,000 $4,473,000
Payables $689,000 $244,000 - -
Accounts Payable $689,000 $244,000 - -
Other Non Current Liabilities - - $67,000 -
Equity
Common Stock Equity $18,592,000 $38,386,000 $64,895,000 $103,407,000
Total Equity Gross Minority Interest $18,592,000 $38,386,000 $64,895,000 $103,407,000
Stockholders Equity $18,592,000 $38,386,000 $64,895,000 $103,407,000
Gains Losses Not Affecting Retained Earnings $1,000 $-13,000 $-209,000 $-1,004,000
Other Equity Adjustments $1,000 $-13,000 $-209,000 $-1,004,000
Retained Earnings $-283,137,000 $-262,052,000 $-231,895,000 $-197,794,000
Preferred Securities Outside Stock Equity - - - -
Other
Ordinary Shares Number $1,261,685 $1,259,029 $1,251,509 $1,538,208
Share Issued $1,261,685 $1,259,029 $1,251,509 $1,538,208
Tangible Book Value $18,592,000 $38,386,000 $64,895,000 $103,407,000
Invested Capital $18,592,000 $38,386,000 $64,895,000 $103,407,000
Working Capital $17,256,000 $36,481,000 $61,607,000 $99,523,000
Capital Lease Obligations $1,509,000 $3,845,000 $6,208,000 $8,033,000
Total Capitalization $18,592,000 $38,386,000 $64,895,000 $103,407,000
Additional Paid In Capital $301,728,000 $300,451,000 $296,996,000 $302,202,000
Capital Stock $0 $0 $3,000 $3,000
Common Stock $0 $0 $3,000 $3,000
Preferred Stock $0 $0 $0 $0
Long Term Capital Lease Obligation $59,000 $1,527,000 $3,769,000 $5,902,000
Current Capital Lease Obligation $1,450,000 $2,318,000 $2,439,000 $2,131,000
Pensionand Other Post Retirement Benefit Plans Current $1,320,000 $1,882,000 $1,510,000 $2,462,000
Current Accrued Expenses $715,000 $878,000 - -
Net PPE $1,377,000 $3,384,000 $7,038,000 $9,723,000
Accumulated Depreciation $-540,000 $-1,496,000 $-1,727,000 $-1,443,000
Gross PPE $1,917,000 $4,880,000 $8,765,000 $11,166,000
Leases $253,000 $253,000 $253,000 $253,000
Other Properties $1,295,000 $4,273,000 $7,980,000 $10,381,000
Machinery Furniture Equipment $369,000 $354,000 $532,000 $532,000
Properties $0 $0 $0 $0
Other Short Term Investments $12,516,000 $31,341,000 $52,746,000 $89,321,000
Treasury Shares Number - - $0 -
Fetched: 2026-06-17
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-20,469,000 $-24,816,000 $-32,203,000 $-39,347,000
Operating Activities
Operating Cash Flow $-20,453,000 $-24,670,000 $-32,023,000 $-39,026,000
Cash Flow From Continuing Operating Activities $-20,453,000 $-24,670,000 $-32,023,000 $-39,026,000
Operating Gains Losses - - $302,000 $-30,000
Investing Activities
Capital Expenditure $-16,000 $-146,000 $-180,000 $-321,000
Investing Cash Flow $19,772,000 $22,440,000 $38,412,000 $49,949,000
Cash Flow From Continuing Investing Activities $19,772,000 $22,440,000 $38,412,000 $49,949,000
Financing Activities
Repurchase Of Capital Stock $-1,000 $0 $-10,384,000 $0
Financing Cash Flow $-645,000 $-787,000 $-11,173,000 $-287,000
Cash Flow From Continuing Financing Activities $-645,000 $-787,000 $-11,173,000 $-287,000
Net Other Financing Charges $-3,000 $-10,000 $-76,000 -
Net Common Stock Issuance $-1,000 $0 $-10,384,000 $0
Issuance Of Capital Stock - - - $0
Net Preferred Stock Issuance - - - $0
Preferred Stock Issuance - - - $0
Common Stock Issuance - - - $0
Other
Repayment Of Debt $-790,000 $-811,000 $-761,000 $-629,000
Issuance Of Debt $142,000 $0 - -
End Cash Position $8,668,000 $9,994,000 $13,011,000 $17,795,000
Beginning Cash Position $9,994,000 $13,011,000 $17,795,000 $7,159,000
Changes In Cash $-1,326,000 $-3,017,000 $-4,784,000 $10,636,000
Proceeds From Stock Option Exercised $7,000 $34,000 $48,000 $342,000
Common Stock Payments $-1,000 $0 $-10,384,000 $0
Net Issuance Payments Of Debt $-648,000 $-811,000 $-761,000 $-629,000
Net Long Term Debt Issuance $-648,000 $-811,000 $-761,000 $-629,000
Long Term Debt Payments $-790,000 $-811,000 $-761,000 $-629,000
Long Term Debt Issuance $142,000 $0 - -
Net Investment Purchase And Sale $19,538,000 $22,586,000 $38,426,000 $50,255,000
Sale Of Investment $44,693,000 $67,181,000 $59,575,000 $97,124,000
Purchase Of Investment $-25,155,000 $-44,595,000 $-21,149,000 $-46,869,000
Net PPE Purchase And Sale $234,000 $-146,000 $-14,000 $-306,000
Sale Of PPE $250,000 $0 $166,000 $15,000
Purchase Of PPE $-16,000 $-146,000 $-180,000 $-321,000
Change In Working Capital $-1,592,000 $-489,000 $-4,330,000 $1,008,000
Change In Other Working Capital $-562,000 $666,000 $-650,000 $709,000
Change In Other Current Liabilities $-1,586,000 $-1,648,000 $-1,272,000 $-1,141,000
Change In Other Current Assets $80,000 $244,000 $22,000 $5,000
Change In Payables And Accrued Expense $233,000 $-445,000 $-2,331,000 $2,017,000
Change In Prepaid Assets $243,000 $694,000 $-99,000 $-582,000
Other Non Cash Items $1,510,000 $1,554,000 $1,357,000 $1,194,000
Stock Based Compensation $1,274,000 $3,135,000 $4,454,000 $5,812,000
Asset Impairment Charge $0 $951,000 $0 -
Amortization Of Securities $-699,000 $-986,000 $-1,056,000 $231,000
Depreciation Amortization Depletion $139,000 $1,322,000 $1,351,000 $1,347,000
Depreciation And Amortization $139,000 $1,322,000 $1,351,000 $1,347,000
Depreciation $139,000 $1,322,000 $1,351,000 $1,347,000
Net Income From Continuing Operations $-21,085,000 $-30,157,000 $-34,101,000 $-48,588,000
Gain Loss On Sale Of PPE - $0 $302,000 $-15,000
Interest Paid Supplemental Data - - - $0
Gain Loss On Investment Securities - - - $-15,000
Net Business Purchase And Sale - - - -
Purchase Of Business - - - -
Change In Accrued Expense - - - -
Change In Interest Payable - - - -
Change In Payable - - - -
Change In Account Payable - - - -
Fetched: 2026-06-17